These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 108113)

  • 1. Anti-V region framework antibodies affect the ligand binding of VL dimer.
    Ben-Neriah Y; Givol D; Gavish M
    Eur J Immunol; 1979 Jan; 9(1):91-3. PubMed ID: 108113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
    Kabat EA; Wu TT
    J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M; Stollar BD
    J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to immunoglobulin heavy chain variable regions protect helper cells from specific suicide by radiolabeled antigen.
    Puri J; Ben-Neriah Y; Givol D; Lonai P
    Eur J Immunol; 1980 Apr; 10(4):281-4. PubMed ID: 6156844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the domain-domain interaction in the construction of the antigen combining site. A comparative study by 1H-15N shift correlation NMR spectroscopy of the Fv and Fab fragments of anti-dansyl mouse monoclonal antibody.
    Takahashi H; Tamura H; Shimba N; Shimada I; Arata Y
    J Mol Biol; 1994 Oct; 243(3):494-503. PubMed ID: 7966275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
    J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between hypervariable regions, antigen-binding specificity and the three-dimensional structure of antibodies.
    Jaton JC; Riesen W
    Ann Immunol (Paris); 1976; 127(3-4):273-83. PubMed ID: 60900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in the variable region of the lambda 2 chain of M315 suppression of antibodies to the idiotype of M315.
    Sakato N; Azuma T; Fujio H
    Biken J; 1985 Dec; 28(3-4):51-8. PubMed ID: 2423068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
    Rinfret A; Horne C; Dorrington KJ; Klein M
    J Immunol; 1985 Oct; 135(4):2574-81. PubMed ID: 3928754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining site and antigenic determinants of the V regions.
    Givol D; Gavish M; Zakut R; Ben-Neriah Y; Lonai P
    Haematologia (Budap); 1978-1979; 12(1-4):15-24. PubMed ID: 94027
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiolipin binding a light chain from lupus-prone mice.
    Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
    Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
    Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
    Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
    Arndt KM; Müller KM; Plückthun A
    Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunochemical study of the conformational properties of the variable and constant domains of the light chain of mouse MOPC myeloma immunoglobulin].
    Petrosian MN; Vengerova TI; Rokhlin OV
    Mol Biol (Mosk); 1980; 14(5):1187-92. PubMed ID: 6158677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complete V domain amino acid sequences of two myeloma inulin-binding proteins.
    Johnson N; Slankard J; Paul L; Hood L
    J Immunol; 1982 Jan; 128(1):302-7. PubMed ID: 6798111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.